Ibonds 2034 (ID34) 銘柄情報

DOGECOINX $1 TARGET

Trump & the THIRD TEMPLE 2025: End Times SECRET Construction & Israel’s Red Heifers

https://youtu.be/jbh5lxSxFO4

Natural gas seems due to plummet with China

out of buying market now...

Nat gas drillers already shut in wells

last year to slow production...

So, companies didn't need the rift with

China that was started...

T

Hate to be a buzz-kill but I'm having a hard time getting excited when we are still almost $5 DOLLARS BELOW the SP before all of this SPAC/Reverse Merger Management Hail Mary...... we still have about 300% to go before we just break even and dig ourselves out of the hole that management dug for us

This is... Surprising:

https://x.com/gunsnrosesgirl3/status/1887382797490454782

You have to get up to 300 mil+. 50-100 mil ain’t gonna do it. Start bidding.

https://m.youtube.com/watch?v=Jl-nqWTt54w

Wave makes 2FA Simple Yet Secure!!! While Okta lays off 180 people, ESW Holdings Inc. (Wave) has about 50 people dedicated to security that gets the job done!!! Those using Okta could make a smart decision and switchover to Wave rather than

Very true.  3rd party seller.  It's about what will be brought here though.   I've never owned a share here or any other action besides being curious.  I know this will recover and prosper, just how the world works.

we give me those prices i will buy them to because i am in otc the land where fairy dust will make a bankrupt stock as u say pump to moon fue thousand gamble hear or there can payout will see i dont fold i ride the hand till the end and write it off but i flipped some and still in profit so i wil

Went back and studied the posting.
Read X. Understand now. 

I firmly believe that if NWBO was pursuing Agnostic approval, they would have told us.

I do not think this will happen at first get-go.

been in and around this industry all my life this price seems cheap and manipulated and the fact that we have so many accross platforms taking time to warn everyone i am increasingly optomistic scrap is down these company stockpile now and make huge profits when manufacturing pics up hell 5 years a

🎿RP shake out 🐳 SHAKE SHAKE SHAKE

You have not been paying attention. There are other reasons to have approval based in the UK.

Yes I use it but don't post. I wasn't able to bring up the "blue" postings.
Not on X at all. Good luck to you.

Hundreds of healthcare groups urge Trump to protect Medicaid
January 24, 2025
By Ron Southwick

Health leaders are worried about the prospect of reduced aid to Medicaid, which they say would reduce access to care and deal a financial blow to hospitals.

More

Tomorrow is going to be a chit storm of buying here. MCIC just jumped to a 9 million dollar market cap with the new shares that Ben has obviously given someone for a merger. See all you all at .02C tomorrow night without news. Something major is cooking here. Glad it's not cattle feed.

One of these days patience will pay off.

Coretec mentioned this in the 8-K on Nov 14, 2024.

“Failure to meet this deadline could result in a loss of our current filer status. Even when we regain status as a current filer by filing timely reports with current financial statements, we will not be eligible to use a registration

That's an interesting thought.

But... might it really be in part the opposite? Is it possible he DOES feel he doesn't have all that much time left, and wants to go through his bucket list at breakneck speed? And, because he's trying to decide what's most important to him, takes up one

However all of this plays out in the coming weeks, I hope if there is to be a major change in how things are handled...I hope we are able to get at least some kind of one time payout event on the RNVA shares we hold before any important dates in March. Especially for those who have been in and hold

LOL !!!! Please look at the number of UK glioblastoma patient in UK per year, then multiply this number X $200 000.

Writte the answer down.

Now find out what is the NHS budget, yearly.

Compare the numbers...

After doing this, tell me you s

The primary objective of this phase I trial is to assess the safety and feasibility of the treatment.
Notably, one patient experienced an exceptional 80% reduction in tumor size during this trial so far. Such a significant response is uncommon in phase I trials, which are primarily designed t